Medtronic Plc (MDT)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Medtronic Plc (MDT)
Go deeper and ask any question about MDT
Company Performance
Current Price
as of Sep 13, 2024$90.00
P/E Ratio
30.28
Market Cap
$115.42B
Description
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Metrics
Overview
- HQGalway, GA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerMDT
- Price$900.00%
Trading Information
- Market Cap$115.42B
- Float99.92%
- Average Daily Volume (1m)6,763,180
- Average Daily Volume (3m)6,364,060
- EPS$2.98
Company
- Revenue$32.58B
- Rev Growth (1yr)2.77%
- Net Income$1.04B
- Gross Margin59.53%
- EBITDA Margin25.58%
- EBITDA$2.03B
- EV$122.27B
- EV/Revenue3.75
- P/E30.28
- P/S3.58